15.98
price up icon0.38%   0.06
after-market Handel nachbörslich: 15.98
loading

Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- -0.44 - -
Operating Expenses
5.49%
42.99
45.48 44.80 37.60 62.76
Operating Income/Loss
5.49%
-42.99
-45.48 -45.24 -37.60 -62.76
Income/Loss From Continuing Operations Before Tax
5.91%
-37.34
-39.69 -39.18 -32.21 -58.14
Income/Loss From Continuing Operations After Tax
46.07%
-37.34
-25.56 -39.18 -32.21 -58.14
Net Income/Loss
46.07%
-37.34
-25.56 -39.18 -32.21 -58.14
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
89.09%
-0.192
-1.76 - - -0.179
Basic Average Shares
10,141%
43.01
0.42 42.73 39.95 40.68
Diluted Average Shares
10,141%
43.01
0.42 42.73 39.95 40.68
Basic Earnings Per Share
59.26%
-0.86
-0.54 -0.91 -0.82 -1.42
Diluted Earnings Per Share
59.26%
-0.86
-0.54 -0.91 -0.82 -1.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):